Clinical profile, adequacy of dosage and thromboembolic and bleeding outcomes in patients with nonvalvular atrial fibrillation treated with rivaroxaban in a regional hospital of Asturias, Spain

Future Cardiology
Sara Muñiz LobatoMarlén Morán Alcalá

Abstract

To analyze the clinical profile and outcomes of patients with nonvalvular atrial fibrillation treated with rivaroxaban in a regional hospital. Retrospective study of patients with nonvalvular atrial fibrillation that started treatment with rivaroxaban between July 2013 and May 2017 in a regional hospital. 189 patients (age 76.0 ± 9.4 years; CHA2DS2-VASc 4.1 ± 1.7; HAS-BLED 2.1 ± 0.9) were included. Rivaroxaban 20 mg was taken by 74.1% of patients. Among patients treated with rivaroxaban 20 and 15 mg, only 3.6 and 22.5%, respectively, received an inadequate dose. After 26.6 ± 11.6 months of treatment, annual discontinuation rate was 1%. Rates of stroke, major bleeding and intracranial hemorrhage were 0.45, 0.22 and 0.22 events/100 patient years, respectively. In our practice of regional hospital, rates of discontinuation, thromboembolic and bleeding outcomes are low.

References

Feb 25, 2009·European Journal of Internal Medicine·Philippe AmouyelHervé Lamarque
Aug 13, 2011·The New England Journal of Medicine·Manesh R PatelUNKNOWN ROCKET AF Investigators
Feb 15, 2013·Expert Review of Cardiovascular Therapy·Vivencio Barrios, Carlos Escobar
Feb 20, 2015·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Jan Beyer-WestendorfNorbert Weiss
Aug 28, 2016·European Heart Journal·Paulus KirchhofUNKNOWN ESC Scientific Document Group
Mar 21, 2017·Expert Review of Cardiovascular Therapy·Gonzalo Barón-EsquiviasMarcelo Sanmartín Fernandez
Mar 24, 2017·International Journal of General Medicine·Maegan M WhitworthEric J MacLaughlin
Jun 10, 2017·Journal of the American College of Cardiology·Xiaoxi YaoPeter A Noseworthy
Aug 31, 2017·Journal of Managed Care & Specialty Pharmacy·Colleen A McHorneyEric D Peterson
Oct 19, 2017·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·A John CammEric Peterson

❮ Previous
Next ❯

Citations

Apr 1, 2021·Journal of Comparative Effectiveness Research·Marcelo Sanmartín FernándezUNKNOWN the EMIR Study Investigators:

❮ Previous
Next ❯

Software Mentioned

SPSS
XANTUS

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.